Related Experiment Videos
Pretreatment scalene node biopsy in cervical carcinoma
M Trinci1, N Raffetto, V Petrozza
1Dept. of Radiation Oncology, University La Sapienza, Rome, Italy.
European Journal of Gynaecological Oncology
|January 1, 1988
Summary
Scalene node biopsy in cervical cancer patients can identify metastases, particularly when pelvic and paraaortic nodes are involved. Sinus histiocytosis suggests a favorable prognosis, but biopsy is not routine.
Area of Science:
- Oncology
- Surgical Pathology
Background:
- Cervical cancer staging relies on accurate assessment of lymph node involvement.
- The role of scalene lymph node biopsy in detecting distant metastases from cervical cancer requires clarification.
Purpose of the Study:
- To determine the incidence of scalene lymph node metastases in patients with carcinoma of the cervix.
- To assess the prognostic significance of sinus histiocytosis in scalene lymph nodes.
Main Methods:
- 20 patients with cervical cancer underwent scalene fat-pad node biopsy.
- Patients were staged using FIGO criteria; abdominal lymph nodes were evaluated via CT and lymphangiography.
Main Results:
- Scalene node metastases were identified in 2 patients with clinically suspicious nodes and concurrent pelvic and paraaortic lymph node involvement.
- Seven patients exhibited sinus histiocytosis in scalene node biopsies, correlating with a potentially better prognosis.
Conclusions:
- Scalene node biopsy is not a routine diagnostic procedure for cervical cancer.
- Biopsy is recommended for patients with palpable supraclavicular masses or confirmed paraaortic lymph node involvement.